Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study

by Francesco Patti, Javier Nicolas Penaherrera, Lorissa Zieger, Eva-Maria Wicklein
Published 2021-08-01

Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure

by Kerstin Hellwig, Fernando Duarte Caron, Eva-Maria Wicklein, Aasia Bhatti, Alessandra Adamo
Published 2020-03-01